Richard advises individual inventors, companies of all sizes, and academic institutions working in the life sciences and medical device art areas on intellectual property matters. Richard's experience includes US and foreign patent preparation, prosecution, due diligence as well as the preparation of patentability, infringement, validity, and freedom-to-operate opinions.
He has helped clients protect inventions involving protein and small molecule pharmaceuticals, antibody therapeutics, vaccines, gene therapy, genetic engineering, antisense technology, genomics, tissue regeneration and organogenesis, stem cell-derived technologies, lead compound discovery and development, model organ screening assays for gene and drug discovery, drug delivery systems, nucleic acid- and protein chip-based technologies, bioinformatics analysis, nanobiotechnology, biological imaging, medical devices, microfluidics, and biofuels.
Prior to Mintz Levin, Richard served as a technology specialist at a global law firm and an IP boutique, and then as a patent attorney at another global law firm. Richard also has 17 years of research experience spanning genetics, microbiology, cell biology, and computational biology. He did his post-doctoral work in the Department of Genetics at Harvard Medical School, where he analyzed two Drosophilia homologs of bmi-1, a leukemia-causing gene in humans, involved in epigenetic gene regulation. He also received research grants from the Howard Hughes Medical Institute, the Pew Charitable Trust, and the National Institutes of Health.
Recognitions & Awards
• Boston Super Lawyers: Rising Star (2014)
Professional & Community Involvement
• Board member, Little Cumberland Island Wildlife Refuge (06.2013 - Present)
• Member, Long Range Planning Committee, Little Cumberland Island Wildlife Refuge (06.1996 - 2006)